
David Monroe
Articles
-
Jan 17, 2025 |
onlinelibrary.wiley.com | Joshua N Farr |David Monroe |Elizabeth Atkinson |Mitchell N. Froemming
1 Introduction There is now substantial pre-clinical evidence, principally from mouse models, that the clearance of senescent cells ameliorates a range of age-associated comorbidities (reviewed in Chaib, Tchkonia, and Kirkland 2022).
-
Nov 5, 2024 |
medrxiv.org | Joshua N Farr |David Monroe |Elizabeth Atkinson |Mitchell N. Froemming
The authors have declared no competing interest. NCT04313634This work was supported by National Institutes of Health grants R21 AG065868 (J.N.F. and S.K.), P01 AG062413 (S.K., D.G.M.), R01 AG076515 (S.K., D.G.M.), R01 AG086085 (S.K., D.G.M.), Hevolution HR-GRO-23-1199144-8 (S.K., D.G.M.), and R01 DK128552 (J.N.F.). The funders played no role in the conduct or analyses of this study.
-
Jul 2, 2024 |
nature.com | Joshua N Farr |Jad G. Sfeir |Dominik Saul |Kai Yu |Tamara Tchkonia |Nathan K. LeBrasseur | +2 more
AbstractPreclinical evidence demonstrates that senescent cells accumulate with aging and that senolytics delay multiple age-related morbidities, including bone loss. Thus, we conducted a phase 2 randomized controlled trial of intermittent administration of the senolytic combination dasatinib plus quercetin (D + Q) in postmenopausal women (n = 60 participants).
-
Apr 3, 2024 |
nywire.com | David Monroe
By: David MonroeIn the vibrant tapestry of the global art scene, a name that resonates with an increasingly fervent echo is that of Colombian artist Victor Ospina. Known for his profound ability to weave the rich cultural heritage of Colombia into the fabric of modern artistry, Ospina has not just captured the imagination of art aficionados worldwide but has also become a beacon of cultural pride for his homeland.
-
Jul 31, 2023 |
nature.com | Madison L. Doolittle |Dominik Saul |Kevin D Pavelko |Joshua N Farr |David Monroe
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →